Profile | GDS4304 / 212332_at |
Title | ATP effect on acute myeloid leukemia lymphoblasts |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM766225 | untreated AML 2B blasts | 393.297 | 87 |
GSM766227 | untreated AML 3 blasts | 316.594 | 85 |
GSM766229 | untreated AML 4B blasts | 262.921 | 82 |
GSM766226 | ATP-treated AML 2B blasts | 379.403 | 87 |
GSM766228 | ATP-treated AML 3 blasts | 256.367 | 84 |
GSM766230 | ATP-treated AML 4B blasts | 237.526 | 81 |
GSM766231 | untreated AML 6B blasts | 147.864 | 75 |
GSM766233 | untreated AML 7C blasts | 679.427 | 93 |
GSM766245 | untreated AML 13 blasts | 213.612 | 80 |
GSM766232 | ATP-treated AML 6B blasts | 133.988 | 74 |
GSM766234 | ATP-treated AML 7C blasts | 588.397 | 91 |
GSM766246 | ATP-treated AML 13 blasts | 208.895 | 80 |
GSM766235 | untreated AML 8 blasts | 390.842 | 87 |
GSM766237 | untreated AML 9 blasts | 133.032 | 74 |
GSM766247 | untreated AML 14 blasts | 315.127 | 84 |
GSM766236 | ATP-treated AML 8 blasts | 457.672 | 89 |
GSM766238 | ATP-treated AML 9 blasts | 123.913 | 73 |
GSM766248 | ATP-treated AML 14 blasts | 262.095 | 82 |
GSM766239 | untreated AML 10 blasts | 223.497 | 81 |
GSM766241 | untreated AML 11 blasts | 227.124 | 82 |
GSM766243 | untreated AML 12 blasts | 317.453 | 85 |
GSM766240 | ATP-treated AML 10 blasts | 157.157 | 77 |
GSM766242 | ATP-treated AML 11 blasts | 264.645 | 84 |
GSM766244 | ATP-treated AML 12 blasts | 243.226 | 81 |